Although the evidence is limited and more research is needed, there is also evidence that FGF21 analogs may potentially reduce liver fibrosis, and others are being evaluated to assess their efficacy, safety, and tolerability in patients with cirrhosis [84]. Here, FGF21 is linked to Hepatic fibrosis.